A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2004
11/24/2004	EP1478395A2 Rapid lateral flow assay for determining exposure to mycobacterium tuberculosis and other mycobacteria
11/24/2004	EP1478392A2 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
11/24/2004	EP1478391A1 Method of providing prophylaxis for tuberculosis in hiv positive individuals
11/24/2004	EP1478390A2 Novel complexes for inducing an immune response
11/24/2004	EP1478371A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/24/2004	EP1233984B1 PROCESS FOR PRODUCING WASP POISON ALLERGENS WITH REDUCED IgE-REACTIVITY
11/24/2004	EP1214340B1 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
11/24/2004	EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004	EP1171587B1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
11/24/2004	EP1105155B1 Vaccine comprising cytokine-induced heat shock proteins (hsp)
11/24/2004	EP1078105B1 Replication defective hiv vaccine
11/24/2004	EP1049787B1 Multipurpose antibody derivatives
11/24/2004	EP1024830B1 Antigen vectors in the form of multilamellar vesicles
11/24/2004	EP1007677B1 Protease-related protein
11/24/2004	EP0998493B1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
11/24/2004	EP0971738B1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants
11/24/2004	EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
11/24/2004	EP0946185B1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
11/24/2004	EP0929318B1 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same
11/24/2004	EP0889731B1 Injectable therapy for control of muscle spasms and pain related to muscle spasms
11/24/2004	EP0830140B1 A pluripotent vaccine against enveloped viruses
11/24/2004	EP0745129B1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
11/24/2004	EP0717752B1 Therapeutic compounds
11/24/2004	EP0656012B1 T cell epitopes of ryegrass pollen allergen
11/24/2004	CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses
11/24/2004	CN1549728A Immune composition containing antigen, gene vector and adjuvant
11/24/2004	CN1549727A Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
11/24/2004	CN1549726A Innate immune system-directed vaccines
11/24/2004	CN1548542A Recombinant DNA plasmid, its construction process, mutivalent vaccine containing the plasmid and its application
11/24/2004	CN1548540A Polypeptide enzyme surface exhibiting technology and C-end polypeptide enzyme surface exhibition of cholesteryl ester transfer protein
11/24/2004	CN1548537A Vaccine preparing process and antitumor vaccine
11/24/2004	CN1548532A Recombinant adenovirus vaccine containing latent membrane protein-2 gene of EB virus
11/24/2004	CN1548457A Tumor antigen protein and tumor antigen peptide
11/24/2004	CN1548455A Tumor antigen protein and tumor antigen peptide
11/24/2004	CN1548156A Hepatitis B treating vaccine prepn and its prepn process and use
11/24/2004	CN1548155A Vaccine composition stable at normal temperature and its prepn
11/24/2004	CN1548150A Sheep lamb increasing essence
11/24/2004	CN1177053C Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
11/24/2004	CN1177046C Enhanced virus-mediated DNA transfer
11/24/2004	CN1176948C Single-chain antibody resisting HIV-1 outer membrane protein and recombinant immunotoxin
11/24/2004	CN1176945C Plasmodium fused antigen and its preparing process usage
11/23/2004	US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders
11/23/2004	US6822071 Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821957 Vectors containing neutralizing motifs and/or a reduced number of immunostimulatory cpg motifs and methods of use for gene therapy protocols
11/23/2004	US6821955 Immobilized vaccine; gene therapy
11/23/2004	US6821754 Staphylococcus aureus genes and polypeptides
11/23/2004	US6821742 Conformational and topological protein regulation
11/23/2004	US6821723 Polypeptide mimics the intermediate state of gp41 and is capable of inducing antibodies which neutralize primary isolates of hiv
11/23/2004	US6821521 Multicomponent meningococcal vaccine
11/23/2004	US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004	US6821517 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/23/2004	US6821515 Protein formulation
11/23/2004	US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
11/23/2004	CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor
11/23/2004	CA2260835C Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
11/23/2004	CA2134239C Pretargeting methods and compounds
11/23/2004	CA2131709C Immune-enhancing agent for therapeutic use in immunocompromised hosts
11/23/2004	CA2012482C Hepatitis c diagnostics and vaccines
11/22/2004	CA2441681A1 Cancer monitoring and therapeutics
11/18/2004	WO2004099422A2 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
11/18/2004	WO2004099418A1 Fused protein
11/18/2004	WO2004099389A2 Dna vaccines against tumor growth and methods of use thereof
11/18/2004	WO2004099253A1 Method of detecting probnp with a monoclonal antibody binding to the amino acid 41-46
11/18/2004	WO2004099252A1 Method of detecting native probnp with amonoclonal antibody binding to the amino acids 38-44
11/18/2004	WO2004099247A2 Synthetic gene encoding human carcinoembryonic antigen and uses thereof
11/18/2004	WO2004099244A2 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
11/18/2004	WO2004098645A1 Immunoglobulin conjugates of autoantigens and their use in the prevention of disease
11/18/2004	WO2004098637A1 Tgf-beta antagonists combined with renin-angiotensin-aldosteron-system antagonists for treating renal insufficiency
11/18/2004	WO2004098636A2 Vaccinating against infectious diseases using proteosomes
11/18/2004	WO2004098631A1 Alzheimer's disease treatment method
11/18/2004	WO2004098598A1 COMPOSITION COMPRISING ROFLUMILAST AND A TNFα ANTAGONIST
11/18/2004	WO2004098578A2 Composition comprising a pde4 inhibitor and a tnf-alfa antagonist selected from infliximab, adalimumab, cdp870 and cdp517
11/18/2004	WO2004098535A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/18/2004	WO2004098533A2 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/18/2004	WO2004098529A2 Therapeutic compositions and vaccines by glycosyl-phosphatidylinositol (gpi)-anchored cytokines and immunostimulatory molecules
11/18/2004	WO2004098526A2 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
11/18/2004	WO2004098509A2 Compositions for inducing immune responses
11/18/2004	WO2004098497A2 Cd4+ human papillomavirus (hpv) epitopes
11/18/2004	WO2004098491A2 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES
11/18/2004	WO2004089980A3 Therapeutic cancer vaccine
11/18/2004	WO2004085648A3 Nogo receptor binding protein
11/18/2004	WO2004075836A9 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS
11/18/2004	WO2004043353A3 Compositions and methods for treating acute myeloid leukemia
11/18/2004	WO2004037997A3 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof
11/18/2004	WO2004002528A9 Compositions and methods for therapeutic treatment
11/18/2004	WO2003093443A3 Alcam and alcam modulators
11/18/2004	WO2003087021A8 Nanoparticle delivery systems and methods of use thereof
11/18/2004	WO2003076591A8 Compositions and methods for generating an immune response
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2002090499A3 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/18/2004	US20040230067 Using alpha beta unsaturated cyclohexanone derivative as inductors; higher recognizing property of targeted acceptor substance
11/18/2004	US20040230051 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040229945 use in inhibiting angiogenesis in a mammal
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
11/18/2004	US20040229832 Vaccines containing ribavirin and methods of use thereof
11/18/2004	US20040229809 Immunogenic peptides from the HPV E7 protein

1 ... 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 ... 1823